Benefit of Allogeneic Transplantation in Patients Age ≥ 60 Years with Acute Myeloid Leukemia Is Limited to Those in First Complete Remission at Time of Transplant-Reference-Cited by-同舟云学术

Benefit of Allogeneic Transplantation in Patients Age ≥ 60 Years with Acute Myeloid Leukemia Is Limited to Those in First Complete Remission at Time of Transplant

Published:2014-04 Issue:4 Volume:20 Page:474-479
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Michelis Fotios V.,Messner Hans A.,Atenafu Eshetu G.,Kim Dennis D.,Kuruvilla John,Lipton Jeffrey H.,Uhm Jieun,Loach David,Gupta Vikas

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference20 articles.

1. Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia: myths, controversies, and unknowns;Gupta;Blood,2011

2. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials;Koreth;JAMA,2009

3. Curability of patients with acute myeloid leukemia who did not undergo transplantation in first remission;Burnett;J Clin Oncol,2013

4. Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?;Horan;J Clin Oncol,2011

5. Prognostic factors in allo-SCT of elderly patients with AML;Krauter;Bone Marrow Transplant,2011

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to improve the outcomes of elderly acute myeloid leukemia patients through allogeneic hematopoietic stem cell transplantation;Frontiers in Immunology;2023-05-03

2. Optimizing Transplant Approaches and Post-Transplant Strategies for Patients With Acute Myeloid Leukemia;Frontiers in Oncology;2021-04-15

3. Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT;Leukemia;2019-07-30

4. Influence of FLT3-ITD and NPM1 status on allogeneic hematopoietic cell transplant outcomes in patients with cytogenetically normal AML;European Journal of Haematology;2019-02-13

5. Outcome of allografting for AML-CR2 is equivalent across BSBMT and EBMT and is associated with encouraging OS and DFS across all age groups;Bone Marrow Transplantation;2019-01-24